Calycosin-7-O-β-d-glucopyranoside stimulates osteoblast differentiation through regulating the BMP/WNT signaling pathways

Acta Pharmaceutica Sinica B

Volumn 5, Issue 5, 2015, Pages 454-460

  Jian, Jing ^a   Sun, Lijuan ^a   Cheng, Xun ^a   Hu, Xiaofang ^a   Liang, Jichao ^a   Chen, Yong ^a  

^a HUBEI UNIVERSITY   (China)

Author keywords

BMP signaling pathway; Calycosin 7 O D glucopyranoside; Osteoblastic differentiation; ST2 cells; WNT catenin signaling pathway

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CALYCOSIN 7 O BETA DEXTRO GLUCOPYRANOSIDE; DICKKOPF 1 PROTEIN; MESSENGER RNA; NOGGIN; OSTEOCALCIN; PYRANOSIDE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BONE DEVELOPMENT; BONE MARROW STROMA CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; REGULATORY MECHANISM; WNT SIGNALING PATHWAY;

EID: 84947202072     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2015.06.005     Document Type: Article

References (32)

1. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
2. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2011, 13:27-38.
3. Huang W, Yang S, Shao J, Li YP. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 2007, 12:3068-3092.
4. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
5. Kalajzic I, Staal A, Yang WP, Wu YL, Johnson SE, Feyen JHM, et al. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 2005, 280:24618-24626.
6. Lee SS, Sharma AR, Choi BS, Jung JS, Chang JD, Park S, et al. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells. Biomaterials 2012, 33:4251-4263.
7. Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ, et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 2009, 113:517-525.
8. Chen JJ, Zhang NF, Mao GX, He XB, Zhan YC, Deng HB, et al. Salidroside stimulates osteoblast differentiation through BMP signaling pathway. Food Chem Toxicol 2013, 62:499-505.
9. Yesilada E, Bedir E, Çalis I, Takaishic Y, Ohmotod Y. Effects of triterpene saponins from Astragalus species on in vitro cytokine release. J Ethnopharmacol 2005, 96:71-77.
10. Rios JL, Waterman PG. A review of the pharmacology and toxicology of Astragalus. Phytother Res 1997, 11:411-418.
11. Kim C, Ha H, Lee JH, Kim JS, Song K, Park SW. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharm Res 2003, 26:917-924.
12. Kang SC, Kim HJ, Kim MH. Effects of Astragalus membranaceus with supplemental calcium on bone mineral density and bone metabolism in calcium-deficient ovariectomized rats. Biol Trace Elem Res 2013, 151:68-74.
13. Choi SI, Lee YM, Heo TR. Screening of hyaluronidase inhibitory and free radical scavenging activity in vitro of traditional herbal medicine extracts. Korean J Bio-technol Bioeng 2003, 18:282-288.
14. Choi SI, Park SR, Heo TR. Inhibitory effect of Astragali radix on matrix degradation in human articular cartilage. J Microbiol Biotechnol 2005, 15:1258-1266.
15. Taku K, Melby MK, Nishi N, Omori T, Kurzer MS. Soy isoflavones for osteoporosis: an evidence-based approach. Maturitas 2011, 70:333-338.
16. Wei P, Liu M, Chen Y, Chen DC. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med 2012, 5:243-248.
17. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell-line. J Biol Chem 1995, 270:9420-9428.
18. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol 1999, 277:C132-C138.
19. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996, 220:366-371.
20. Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng HW, et al. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2013, 52:145-156.
21. Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003, 18:1842-1853.
22. Aubin JE. Bone stem cells. J Cell Biochem Suppl 1998, 30-31:73-82.
23. Cao X, Chen D. The BMP signaling and in vivo bone formation. Gene 2005, 357:1-8.
24. Zhang JF, Li G, Chan CY, Meng CL, Lin MC, Chen YC, et al. Flavonoids of Herba Epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/β-catenin signaling pathway. Mol Cell Endocrinol 2010, 314:70-74.
25. Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, et al. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling. Biochem Biophys Res Commun 2011, 409:260-265.
26. Huang J, Yuan L, Wang X, Zhang TL, Wang K. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci 2007, 81:832-840.
27. Vali B, Rao LG, El-Sohemy A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007, 18:341-347.
28. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, et al. Structural basis of BMP signaling inhibition by the cystine knot protein Noggin. Nature 2002, 420:636-642.
29. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8:739-750.
30. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, et al. Essential role of β-catenin in postnatal bone acquisition. J Biol Chem 2005, 280:21162-21168.
31. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:1-16.
32. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.